Posts

Showing posts with the label Genomics Market

Genomics Market | Global Market Challenges, Demand, Trends, and Future Opportunities Forecast Till 2026

Image
Genomics is the study of human genes and chromosomes. It focuses on structure, function, evolution, mapping, and editing of genomes. Genome is the genetic material of organism, which includes the Deoxyribonucleic acid (DNA). DNA consists the information needed to build the whole human body. Human genome consists of 23 pairs of chromosomes and 24000 genes. This study is divided into various types such as structural genomics, functional genomics, and comparative genomics. Global Genomics Market Drivers Increasing new product launches is expected to drive the global genomics market growth. For instance, in January 2019, Contextual Genomics launched two molecular hotspot assays (Liquid Biopsy Test and updated Solid Tumor Panel) for the detection of genomic mutations in blood and solid tumors. Furthermore, in May 2015, Rosetta Genomics Ltd. launched OncoGxOne. It is Next Generation Sequencing (NGS) test that profiles tumors for targeted therapy selection and ...

Genomics Market Are Made : An Overview To The Future Opportunities Over The Globe

Image
Genomics is the study of human genes and chromosomes. It focuses on structure, function, evolution, mapping, and editing of genomes. Genome is the genetic material of organism, which includes the Deoxyribonucleic acid (DNA). DNA consists the information needed to build the whole human body. Human genome consists of 23 pairs of chromosomes and 24000 genes. This study is divided into various types such as structural genomics, functional genomics, and comparative genomics. Global Genomics Market Drivers Increasing new product launches is expected to drive the global genomics market growth. For instance, in January 2019, Contextual Genomics launched two molecular hotspot assays (Liquid Biopsy Test and updated Solid Tumor Panel) for the detection of genomic mutations in blood and solid tumors. Furthermore, in May 2015, Rosetta Genomics Ltd. launched OncoGxOne. It is Next Generation Sequencing (NGS) test that profiles tumors for targeted therapy selection and ...